Our results support the previous observations, which showed that immune-repressed triple-negative breast cancers (TNBC) lacking endogenous IFN signaling were highly recurrent, therapy-resistant, and characterized by CSC-like features [67, 68]. The gene discussed is IFNA1; the disease is triple-negative breast carcinoma.